DK1928875T3 - 2-Amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-oner, fremgangsmåder til deres fremstilling samt farmaceutiske sammensætninger indeholdende dem - Google Patents

2-Amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-oner, fremgangsmåder til deres fremstilling samt farmaceutiske sammensætninger indeholdende dem

Info

Publication number
DK1928875T3
DK1928875T3 DK06825272.5T DK06825272T DK1928875T3 DK 1928875 T3 DK1928875 T3 DK 1928875T3 DK 06825272 T DK06825272 T DK 06825272T DK 1928875 T3 DK1928875 T3 DK 1928875T3
Authority
DK
Denmark
Prior art keywords
pyrido
pyrimidin
dihydro
ones
amino
Prior art date
Application number
DK06825272.5T
Other languages
Danish (da)
English (en)
Inventor
Timothy D Machajewski
Cynthia M Shafer
Christopher Mcbride
William Antonios-Mccrea
Brandon M Doughan
Barry H Levine
Maureen Mckenna
X Michael Wang
Kris Mendenhall
Yasheen Zhou
Baoqing Gong
Dan Gu
John Dolan
John Tulinsky
Kristin Brinner
Zhenhai Gao
Yi Xia
Paul A Renhowe
Daniel Poon
Paul A Barsanti
Xiaodong Lin
Teresa Pick
Abran Costales
Nathan Brammeier
Alice Rico
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1928875T3 publication Critical patent/DK1928875T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
DK06825272.5T 2005-09-30 2006-09-28 2-Amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-oner, fremgangsmåder til deres fremstilling samt farmaceutiske sammensætninger indeholdende dem DK1928875T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72279605P 2005-09-30 2005-09-30
US83688606P 2006-08-09 2006-08-09
PCT/US2006/038181 WO2007041362A1 (en) 2005-09-30 2006-09-28 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones

Publications (1)

Publication Number Publication Date
DK1928875T3 true DK1928875T3 (da) 2011-10-03

Family

ID=37661234

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06825272.5T DK1928875T3 (da) 2005-09-30 2006-09-28 2-Amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-oner, fremgangsmåder til deres fremstilling samt farmaceutiske sammensætninger indeholdende dem

Country Status (31)

Country Link
US (2) US7671059B2 (OSRAM)
EP (1) EP1928875B1 (OSRAM)
JP (2) JP5036002B2 (OSRAM)
KR (1) KR101311757B1 (OSRAM)
AR (1) AR058072A1 (OSRAM)
AT (1) ATE514694T1 (OSRAM)
AU (1) AU2006297124B2 (OSRAM)
BR (1) BRPI0616701A2 (OSRAM)
CA (1) CA2624253C (OSRAM)
CR (1) CR9846A (OSRAM)
CY (1) CY1112028T1 (OSRAM)
DK (1) DK1928875T3 (OSRAM)
EA (1) EA016152B1 (OSRAM)
EC (1) ECSP088324A (OSRAM)
GE (1) GEP20115231B (OSRAM)
HR (1) HRP20110655T1 (OSRAM)
IL (1) IL190446A0 (OSRAM)
JO (1) JO2783B1 (OSRAM)
MA (1) MA29885B1 (OSRAM)
ME (1) ME01952B (OSRAM)
MY (1) MY143604A (OSRAM)
NO (1) NO342258B1 (OSRAM)
NZ (1) NZ566914A (OSRAM)
PE (1) PE20070621A1 (OSRAM)
PL (1) PL1928875T3 (OSRAM)
PT (1) PT1928875E (OSRAM)
RS (1) RS51795B (OSRAM)
SM (1) SMAP200800029A (OSRAM)
TN (1) TNSN08143A1 (OSRAM)
TW (1) TWI373471B (OSRAM)
WO (1) WO2007041362A1 (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002994A1 (es) * 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
CN101225083A (zh) * 2007-01-16 2008-07-23 北京摩力克科技有限公司 四氢喹唑啉酮类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
GB2449293A (en) * 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
CN101983191B (zh) * 2008-02-01 2013-11-20 武田药品工业株式会社 作为hsp90抑制剂的肟衍生物
WO2010034670A2 (en) * 2008-09-26 2010-04-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Host cell kinases as targets for antiviral therapies against hcv infection
WO2010060939A2 (en) * 2008-11-28 2010-06-03 Novartis Ag Combination of hsp90 and herceptin inhibitors
US20110230499A1 (en) 2008-11-28 2011-09-22 Novartis Ag Hsp90 inhibitors for therapeutic treatment
CN102227221A (zh) * 2008-11-28 2011-10-26 诺瓦提斯公司 包含hsp90抑制剂和mtor抑制剂的药物组合
AR075180A1 (es) 2009-01-29 2011-03-16 Novartis Ag Formulaciones orales solidas de una pirido-pirimidinona
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
WO2011053861A1 (en) * 2009-10-29 2011-05-05 Genosco Kinase inhibitors
WO2012104823A2 (en) 2011-02-04 2012-08-09 Novartis Ag Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
RU2017119219A (ru) 2011-10-14 2018-11-02 Новартис Аг 2-карбоксамид циклоамино производные мочевины в комбинации с ингибиторами hsp90 для лечения пролиферативных заболеваний
ITTO20111013A1 (it) 2011-11-03 2013-05-04 Dac Srl Composti farmaceutici
CN103664938A (zh) * 2012-09-12 2014-03-26 山东亨利医药科技有限责任公司 含有嘧啶并环的syk抑制剂
RU2015121424A (ru) 2012-11-07 2016-12-27 Новартис Аг Комбинированная терапия
US9677907B2 (en) * 2013-03-14 2017-06-13 Itron Inc Intelligent receptacle
GB201306610D0 (en) * 2013-04-11 2013-05-29 Almac Discovery Ltd Pharmaceutical compounds
ES2848706T3 (es) 2013-09-30 2021-08-11 Taiho Pharmaceutical Co Ltd Terapia de combinación contra el cáncer usando un compuesto azabicíclico
MX2017002544A (es) * 2014-09-02 2017-07-19 Pf Medicament Derivados de isoquinolinona utiles en el tratamiento contra el cancer.
KR20160035411A (ko) * 2014-09-23 2016-03-31 주식회사 오스코텍 LRRK2 (Leucine Rich Repeat Kinase 2) 키나제 억제제로서의 피리도피리미딘 유도체 화합물
KR101653560B1 (ko) * 2016-02-02 2016-09-12 한국화학연구원 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
RU2629599C1 (ru) * 2016-09-28 2017-08-30 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ химиолучевого лечения опухолей прямой кишки и анального канала
JP7229158B2 (ja) 2017-06-09 2023-02-27 中外製薬株式会社 Ｎ－置換アミノ酸を含むペプチドの合成方法
EP4174056A4 (en) * 2020-06-26 2024-08-07 Nihon Nohyaku Co., Ltd. ARYLTETRAHYDROPYRIDINE DERIVATIVE OR SALT THEREOF, INSECTICIDE THEREOF AND METHOD OF USE THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165873A (ja) * 1984-09-07 1986-04-04 Mitsui Petrochem Ind Ltd ２−ピペラジノピリミジン誘導体
US4734418A (en) * 1984-12-14 1988-03-29 Mitsui Petrochemical Industries, Ltd. Quinazoline compounds and antihypertensives
MA21177A1 (fr) 1987-02-11 1988-10-01 May & Baker Ltd Diones cycliques.
CN100376571C (zh) * 2001-02-12 2008-03-26 霍夫曼-拉罗奇有限公司 6-取代的吡啶并嘧啶类化合物
DE102004018198A1 (de) 2004-04-15 2005-11-03 Merck Patent Gmbh Sulfonamide
EP2332527A3 (en) 2004-10-20 2011-11-16 Resverlogix Corp. Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases
WO2006074293A2 (en) * 2005-01-07 2006-07-13 President And Fellows Of Harvard College Bicyclic dihydropyrimidines as eg5 inhibitors
AU2006236557A1 (en) * 2005-04-14 2006-10-26 Novartis Vaccines And Diagnostics Inc. 2-amino-quinazolin-5-ones as HSP90 inhibitors useful in treating proliferation diseases

Also Published As

Publication number Publication date
CA2624253A1 (en) 2007-04-12
CY1112028T1 (el) 2015-11-04
US20070123546A1 (en) 2007-05-31
ME01952B (en) 2011-12-31
PL1928875T3 (pl) 2011-11-30
KR20080057318A (ko) 2008-06-24
EP1928875B1 (en) 2011-06-29
TNSN08143A1 (en) 2009-07-14
JP5036002B2 (ja) 2012-09-26
CA2624253C (en) 2015-06-16
MA29885B1 (fr) 2008-10-03
ECSP088324A (es) 2008-04-28
NO342258B1 (no) 2018-04-30
US20100004237A1 (en) 2010-01-07
AU2006297124B2 (en) 2011-12-08
TW200728304A (en) 2007-08-01
SMP200800029B (it) 2008-05-07
CR9846A (es) 2008-08-01
US7671059B2 (en) 2010-03-02
JO2783B1 (en) 2014-03-15
NO20082069L (no) 2008-06-09
IL190446A0 (en) 2008-11-03
HRP20110655T1 (hr) 2011-10-31
EA016152B1 (ru) 2012-02-28
AR058072A1 (es) 2008-01-23
GEP20115231B (en) 2011-06-10
EP1928875A1 (en) 2008-06-11
WO2007041362A1 (en) 2007-04-12
MY143604A (en) 2011-06-15
NZ566914A (en) 2011-09-30
JP2012158611A (ja) 2012-08-23
PT1928875E (pt) 2011-09-06
AU2006297124A1 (en) 2007-04-12
RS51795B (sr) 2011-12-31
BRPI0616701A2 (pt) 2011-06-28
SMAP200800029A (it) 2008-05-07
KR101311757B1 (ko) 2013-09-26
ATE514694T1 (de) 2011-07-15
PE20070621A1 (es) 2007-09-06
JP2009510108A (ja) 2009-03-12
TWI373471B (en) 2012-10-01
EA200800992A1 (ru) 2008-10-30
HK1118823A1 (en) 2009-02-20

Similar Documents

Publication Publication Date Title
DK1928875T3 (da) 2-Amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-oner, fremgangsmåder til deres fremstilling samt farmaceutiske sammensætninger indeholdende dem
EP1984370A4 (en) PROTEIN KINASE ACTIVITY INHIBITING IMIDAZOPYRIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
IL182121A0 (en) Pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containingthe same
IL191907A0 (en) Azepinoindole derivatives as pharmaceutical agents
IL185390A (en) A solid dosage form
IL192108A (en) Triazulophyridines, pharmaceutical preparations and combinations containing them, process for their preparation and use as modulators of tyrosine kinase
ZA200801945B (en) Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
IL185353A0 (en) Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof
IL180108A (en) Sulfamate and Sulfamide Derivatives, Pharmaceutical Preparations Containing Them, Processes for their Preparation
ZA200707396B (en) Gastroresistant pharmaceutical formulations containing rifaximin
PL1917072T3 (pl) Formulacja witaminowa
IL189737A0 (en) Pyrazine derivatives, their preparation and pharmaceutical compositions containing them
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
IL193141A (en) Compounds including pyrrolo [2,3– d] pyrimidine 7 - yl and sulphamate, pharmaceuticals and their use
ZA200803658B (en) 2-amino-7,8-dihydro-6H-pyrido[4,3-d] pyrimidin-5-ones
DK1910288T3 (da) 3-aminocarbazolsammensætninger, farmaceutiske sammensætninger, der indeholder disse, samt fremgangsmåde til deres fremstilling
WO2007056625A3 (en) Thienopyridine b-raf kinase inhibitors
EP1916251A4 (en) ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
DK1838315T3 (da) Substituerede 4-phenyltetrahydroisoquinoliner, fremgangsmåde til fremstilling heraf, deres anvendelse som medikament samt medikamenter indeholdende dem
ZA200802953B (en) Solid vaccine formulation
PL1707564T3 (pl) Pochodne indanylopiperazyn, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
NO20055167D0 (no) Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
IL193115A0 (en) Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them
DK1784403T3 (da) Pyrrolo[3,2-b]pyridinderivater samt fremgangsmåder til deres fremstilling
NO20051367D0 (no) Nye 4-okso-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazin-6-karboksamid-forbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem